SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Biogen
An SI Board Since August 1996
Posts SubjectMarks Bans Symbol
1686 75 0 BIIB
Emcee:  Harold Engstrom Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
386 Harold, Excellent link... thanks!Annie-8/25/1997
385 Link found on another thread: pnas.org!fyear:1996!fmonth:Nov!tmonth:Aug!tdatedHarold Engstrom-8/25/1997
384 M. Kauffman, Biogen Medical Director, Inflammation Program, will present animalscaram(o)uche-8/11/1997
383 ALL: A positive case study written in Strategy and Business, 3rd quarter, 1997,pragat-8/10/1997
382 This is major news. I thought you might find this post from the IDEC thread inVector1-8/10/1997
381 Found this while looking for Biogen news: Proteins Prevent Transplant RejectioHarold Engstrom-8/9/1997
380 Rick, congrats on your new position with Biogen. You have been a valuable helpVector1-8/5/1997
379 Nice job!! - Congrats on your new position.Flan-8/5/1997
378 Rick- Sorry to see you go, but wish you well. Hope that John pays attention toPuddleGlum-8/5/1997
377 Swansong... I'm writing to let everyone know that I have accepted a new asRick Lundberg-8/5/1997
376 Thanks, Steve, I was beginning to wonder if anyone was out there...Harold Engstrom-8/1/1997
375 Harold- Thanks for keeping this thread alive. I've been lurking all along.PuddleGlum-8/1/1997
374 For what its worth, there was an article in yesterday's Boston Globe about Harold Engstrom-8/1/1997
373 HOPKINTON, Mass., July 28 /PRNewswire/ -- Research published in the scientiHarold Engstrom-7/29/1997
372 CAMBRIDGE, Mass., July 28 /PRNewswire/ -- A team of scientists from OntogenHarold Engstrom-7/29/1997
371 Dear Susan, Thanks for your message regarding your experience with AVONEX(R). Rick Lundberg-7/17/1997
370 Text of Q2 Earnings Conference Call (Cont...) Rick Lundberg: We're havingRick Lundberg-7/17/1997
369 Text of Q2 Earnings Conference Call... Conference Call Operator: Good afternooRick Lundberg-7/17/1997
368 PP - Thanks. I have enjoyed following Biogen over the past few years. It is oneHarold Engstrom-7/17/1997
367 Text of Jim Tobin interview on CNBC on July 11. Ron Insana, co-host: BiotechRick Lundberg-7/16/1997
366 <<Doesn't any one care that this company's core product has actuaVector1-7/16/1997
365 Hi Harold, I don't want to be forcasting anything here but i think we may Power Player-7/16/1997
364 Dear Rick, I know that this thread is supposed to be about BGEN stock, but I waSusan Jaremsek-7/15/1997
363 .... and... 6. Biogen indicated that outlicensing for VLA4 will be completed iHarold Engstrom-7/14/1997
362 DJ, I will be posting the text of the conference call this afternoon. A couplRick Lundberg-7/14/1997
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News